According to filings with the U.S. Securities and Exchange Commission, DermBiont is raising $4,693,564.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Karl Beutner played a key role in…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, DermBiont is raising $2,514,010.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Karl Beutner played a key…
Boston, MA – According to filings with the U.S. Securities and Exchange Commission, DermBiont is raising $39,520,131.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Karl Beutner played a key…